A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy

Non-muscle-invasive bladder cancer (NMIBC) is clinically heterogeneous; thus, many patients fail to respond to treatment and relapse. Here, we identified a molecular signature that is both prognostic and predictive for NMIBC heterogeneity and responses to Bacillus Calmette-Guérin (BCG) therapy. Tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seon-Kyu, Park, Seong-Hwan, Kim, Yeong Uk, Byun, Young Joon, Piao, Xuan-Mei, Jeong, Pildu, Kim, Kyeong, Lee, Hee Youn, Seo, Sung Pil, Kang, Ho Won, Kim, Won Tae, Kim, Yong-June, Lee, Sang-Cheol, Moon, Sung-Kwon, Choi, Yung Hyun, Kim, Wun-Jae, Kim, Seon-Young, Yun, Seok Joong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867154/
https://www.ncbi.nlm.nih.gov/pubmed/33535616
http://dx.doi.org/10.3390/ijms22031450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867154/
https://www.ncbi.nlm.nih.gov/pubmed/33535616
http://dx.doi.org/10.3390/ijms22031450

Ejemplares similares